header logo image

Is Intellia Therapeutics Inc (NTLA) a Winner in the Biotechnology Industry? – InvestorsObserver

January 25th, 2021 12:53 pm

Intellia Therapeutics Inc (NTLA) is near the top in its industry group according to InvestorsObserver. NTLA gets an overall rating of 61. That means it scores higher than 61 percent of stocks. Intellia Therapeutics Inc gets a 75 rank in the Biotechnology industry. Biotechnology is number 32 out of 148 industries.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Intellia Therapeutics Inc (NTLA) stock is lower by -9.74% while the S&P 500 has gained 0.22% as of 3:03 PM on Thursday, Jan 21. NTLA has fallen -$7.85 from the previous closing price of $80.56 on volume of 1,686,398 shares. Over the past year the S&P 500 is up 16.22% while NTLA has gained 396.65%. NTLA lost -$2.28 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Intellia Therapeutics Inc (NTLA) Stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

You May Also Like

Go here to see the original:
Is Intellia Therapeutics Inc (NTLA) a Winner in the Biotechnology Industry? - InvestorsObserver

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick